Curon Stretta GERD Coverage Boost In 2005 Has Sales Force Salivating
This article was originally published in The Gray Sheet
Executive Summary
Curon Medical hopes to quintuple the reimbursement-eligible patient population for its minimally-invasive Stretta gastroesophogeal reflux disease (GERD) treatment by mid-2005
You may also be interested in...
GERD Device Maker’s Experience Exemplifies Coverage Barriers For Small Biz
Curon Medical's five-year battle to surpass 10% of U.S. public and private insurer coverage of its Stretta GERD therapy underscores the difficulties small companies face in navigating the reimbursement process
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.